Fusion Antibodies plc (AIM:FAB)
London · Delayed Price · Currency is GBP · Price in GBX 10.22
-0.53 (-4.92%)
Jul 24, 2026, 4:09 PM GMT
Fusion Antibodies Income Statement
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 1.6 | 1.97 | 1.14 | 2.9 | 4.8 | 4.17 | |
Revenue Growth (YoY) | -18.78% | 72.97% | -60.84% | -39.55% | 15.22% | 6.93% |
Cost of Revenue | 1.24 | 1.54 | 1.18 | 2.33 | 2.33 | 2.14 |
Gross Profit | 0.35 | 0.43 | -0.05 | 0.57 | 2.47 | 2.02 |
Selling, General & Admin | 2.25 | 2.21 | 2.25 | 3.44 | 3.82 | 3.47 |
Other Operating Expenses | -0.37 | - | -0.01 | -0.01 | -0.03 | -0.19 |
Total Operating Expenses | 1.88 | 2.21 | 2.24 | 3.43 | 3.79 | 3.27 |
Operating Income | -1.53 | -1.78 | -2.29 | -2.86 | -1.33 | -1.25 |
Interest Income | 0 | 0.01 | 0 | 0 | 0 | 0 |
Interest Expense | -0.01 | -0 | -0.01 | -0 | -0.01 | -0.02 |
Total Non-Operating Income (Expense) | -0.01 | 0 | -0 | -0 | -0.01 | -0.02 |
Pretax Income | -1.53 | -1.78 | -2.29 | -2.86 | -1.33 | -1.26 |
Provision for Income Taxes | -0.07 | -0.06 | -0.06 | -0.26 | -0.13 | 1.64 |
Net Income | -1.47 | -1.71 | -2.23 | -2.6 | -1.2 | -2.9 |
Net Income to Common | -1.47 | -1.71 | -2.23 | -2.6 | -1.2 | -2.9 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 105 | 96 | 56 | 26 | 26 | 25 |
Shares Outstanding (Diluted) | 105 | 96 | 56 | 26 | 26 | 25 |
Shares Change (YoY) | 9.31% | 72.58% | 113.55% | 0.27% | 1.91% | 15.24% |
EPS (Basic) | -0.01 | -0.02 | -0.04 | -0.10 | -0.05 | -0.11 |
EPS (Diluted) | -0.01 | -0.02 | -0.04 | -0.10 | -0.05 | -0.11 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -1.25 | -1.37 | -1.77 | -1.87 | -0.59 | -1.5 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.03 | -0.07 | -0.02 | -0.06 |
Gross Margin | 22.06% | 21.88% | -3.96% | 19.79% | 51.39% | 48.60% |
Operating Margin | -95.55% | -90.53% | -201.41% | -98.52% | -27.61% | -29.99% |
Profit Margin | -91.92% | -87.18% | -195.95% | -89.49% | -25.01% | -69.60% |
FCF Margin | -78.26% | -69.92% | -155.90% | -64.39% | -12.25% | -36.04% |
EBITDA | -1.42 | -1.67 | -2.07 | -2.49 | -0.57 | -0.54 |
EBITDA Margin | -88.85% | -85.19% | -182.04% | -85.69% | -11.96% | -12.85% |
EBIT | -1.53 | -1.78 | -2.29 | -2.86 | -1.33 | -1.25 |
EBIT Margin | -95.55% | -90.53% | -201.41% | -98.52% | -27.61% | -29.99% |
Effective Tax Rate | 4.31% | 3.60% | 2.75% | 9.20% | 9.98% | -129.35% |